Everstar Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.38M Buy
9,501
+189
+2% +$26.1K 0.62% 36
2026
Q2
$1.2M Sell
9,312
-765
-8% -$89.5K 0.58% 54
2026
Q1
$1.21M Buy
10,077
+58
+0.6% +$6.7K 0.65% 45
2025
Q4
$1.05M Sell
10,019
-642
-6% -$60.3K 0.57% 53
2025
Q3
$895K Buy
10,661
+591
+6% +$48.7K 0.51% 63
2025
Q2
$797K Buy
10,070
+4,808
+91% +$382K 0.49% 62
2025
Q1
$472K Buy
5,262
+1,413
+37% +$132K 0.31% 102
2024
Q4
$383K Sell
3,849
-1,600
-29% -$165K 0.27% 107
2024
Q3
$619K Buy
+5,449
New +$647K 0.42% 65

Other funds holding MRK

Everstar Asset Management's MRK Position: Q3 2026 in Review

Everstar Asset Management increased its Merck (MRK) stake by 2% in Q3 2026, buying an estimated $26.1K and bringing the position to 9,501 shares worth $1.38M. The position accounts for 0.62% of the portfolio, ranked #36.

Everstar Asset Management first reported a position in MRK in Q3 2024 and has held it in 9 quarters since. 3,979 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • Everstar Asset Management held 9,501 shares of Merck worth $1.38M as of Q3 2026.
  • Everstar Asset Management bought 189 Merck shares in Q3 2026, an estimated $26.1K.
  • Merck made up 0.62% of Everstar Asset Management's portfolio in Q3 2026, its #36 holding.
  • Everstar Asset Management first reported a position in Merck in Q3 2024 and has held it in 9 quarters since.
  • 3,979 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Everstar Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.